Skip to content

Early Intervention for Tissue Necrosis After Naja atra(Naja atra)Bite: Efficacy Analysis of Combined Application of Early Radical Debridement, Negative Pressure Drainage and Local Antivenom Infiltration

Early Intervention for Tissue Necrosis After Chinese Cobra(Naja atra)Bite: Efficacy Analysis of Combined Application of Early Radical Debridement, Negative Pressure Drainage and Local Antivenom Infiltration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120852
Enrollment
Unknown
Registered
2026-03-20
Start date
2026-03-20
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tissue necrosis after Naja atra (Chinese cobra) bite

Interventions

Conventional Treatment Group:Conventional Debridement + Intravenous Antivenom Therapy
Combined Treatment Group:Early Radical Debridement + Negative Pressure Drainage + Local Antivenom Infiltration+ Intravenous Antivenom Therapy

Sponsors

Wenzhou People‘s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age 14–85 years, time from snakebite to first hospital visit <= 24 hours; 2. Confirmed bite by Chinese cobra (Naja atra) with on-site or imaging evidence; 3. Local necrosis Grade ?–? (according to the 2018 Chinese Snakebite Classification Standard); 4. Voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Necrosis >= Grade ?, or emergency amputation required due to complicated compartment syndrome; 2. Pregnancy/lactation, severe hepatic or renal insufficiency, coagulation dysfunction, immunodeficiency; 3. History of severe allergy to antivenom or negative pressure drainage materials; 4. Extensive debridement or skin grafting performed before referral; 5. Mental disorders or poor compliance unable to complete follow-up; 6. Simultaneous participation in other interventional clinical studies.

Design outcomes

Primary

MeasureTime frame
Rate of change in necrotic tissue volume at 7 days post-treatment;

Secondary

MeasureTime frame
Time to complete wound epithelialization;

Countries

China

Contacts

Public ContactChenghao Zhang

Wenzhou People‘s Hospital

289256719@qq.com+86 577 6552 2993

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026